MAPK9 and head and neck squamous cell carcinoma: A robust TCRRG-based prognostic signature comprising MAP2K7, MAPK3, MAPK9, ORAI1, PSMA1, UBB, and ZAP70 was subsequently constructed and validated across multiple HNSCC cohorts.